These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 582429)

  • 1. Changes in amino acid metabolism caused by 6-azauridine triacetate: relevance to cancer treatment.
    Slavik M
    Cancer Treat Rep; 1979 Jun; 63(6):1041-4. PubMed ID: 582429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-azauridine triacetate induced hyper beta-alaninemia and its decrease by administration of pyridoxine.
    Slavik M; Blanc O; Smith KJ; Slavik J
    J Nutr Sci Vitaminol (Tokyo); 1983 Oct; 29(5):631-5. PubMed ID: 6198500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 6-azauridine triphosphate in L1210 cells and its possible relevance to cytotoxicity.
    Wotring LL; Townsend LB
    Cancer Res; 1989 Jan; 49(2):289-94. PubMed ID: 2463073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in preference for NaCl following administration of 6-azauridine and 6-azauridine triacetate.
    Catalanotto FA; Slavik M; Danilson D; Keiser HR; Henkin RI
    Pharmacol Ther Dent; 1975; 2(1):25-32. PubMed ID: 1054856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine.
    Slavik M; Smith KJ; Blanc O
    Biochem Pharmacol; 1982 Dec; 31(24):4089-92. PubMed ID: 6186258
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings of the Workshop on Amino Acid Imbalance in the Treatment of Cancer. Introduction: possibilities for biochemically rational chemotherapy for some malignancies with depleting enzymes and antimetabolites of specific amino acids.
    Hanka LJ
    Cancer Treat Rep; 1979 Jun; 63(6):1009-11. PubMed ID: 380799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral action and selectivity of 6-azauridine.
    Rada B; Dragún M
    Ann N Y Acad Sci; 1977 Mar; 284():410-7. PubMed ID: 280143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The thrombogenicity of 6-azouridine.
    Gitel SN; Grieco AJ; Wessler S; Snyderman SE
    Haemostasis; 1979; 8(1):54-7. PubMed ID: 456945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azaribine, homocystinemia, and thrombosis.
    Shupack JL; Grieco AJ; Epstein AM; Sansaricq C; Snyderman SE
    Arch Dermatol; 1977 Sep; 113(9):1301-2. PubMed ID: 578401
    [No Abstract]   [Full Text] [Related]  

  • 10. Lessons from the study of induced alterations in amino acids in patients with cancer.
    Holland JF; Ohnuma T
    Cancer Treat Rep; 1979 Jun; 63(6):1013-8. PubMed ID: 313838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of purine derivatives on the toxicity of pyrazofurin and 6-azauridine towards cultured mammalian cells.
    Gupta RS; Moffat MR
    J Cell Physiol; 1982 Jun; 111(3):291-4. PubMed ID: 6178748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cachexia in cancer: disturbances in the protein and aminoacid metabolism].
    de Blaauw I; Deutz NE; von Meyenfeldt MF
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1408-13. PubMed ID: 10422554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus inhibitory effect of combination of 9-(S)-(2,3-dihydroxypropyl) adenine and 6-azauridine.
    Rada B; Holý A
    Chemotherapy; 1980; 26(3):184-90. PubMed ID: 6153950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 6-azauridine analogues possessing sedative and hypnotic effects.
    Kimura T; Watanabe K; Koshigami M; Miyamoto K; Kondo S; Yamamoto I
    Nucleic Acids Symp Ser; 1992; (27):199-200. PubMed ID: 1283907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serum and urine amino acids in patients with progressive systemic sclerosis treated with 6-azauridine triacetate.
    Slavik M; Lovenberg W; Keiser HR
    Biochem Pharmacol; 1973 Jun; 22(11):1295-300. PubMed ID: 4727783
    [No Abstract]   [Full Text] [Related]  

  • 16. Azaribine-homocystinemia-thrombosis in historical perspective.
    Drell W; Welch AD
    Pharmacol Ther; 1989; 41(1-2):195-206. PubMed ID: 2469090
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical significance of amino acid transformations as affected by pyridoxal phosphate enzymes].
    Braunshteĭn AE
    Vestn Akad Med Nauk SSSR; 1982; (9):3-9. PubMed ID: 6755949
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells.
    Vadgama JV; Wu Y; Shen D; Hsia S; Block J
    Anticancer Res; 2000; 20(3A):1391-414. PubMed ID: 10928049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of metabolic changes caused by 6-azauridine (author's transl)].
    Grafnetterová J; Grafnetter D; Blahosová A
    Cas Lek Cesk; 1974 Jan; 113(3):87-90. PubMed ID: 4434415
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations in metabolism of copper and zinc after administration of 6-azauridine triacetate.
    Slavik M; Danilson DA; Keiser HR; Henkin RI
    Biochem Pharmacol; 1973 Sep; 22(18):2349-52. PubMed ID: 4733685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.